SEC Form D private-offering filing
KAZIA THERAPEUTICS LTD
A new SEC Form D private-offering notice from Sydney Nsw, a $55,251,088 filer-stated offering target in Biotech. The source filing is one click away.
Australian clinical-stage oncology company developing cancer therapies, including paxalisib for glioblastoma (brain cancer); listed on ASX and Nasdaq.
Filed 2025-12-18Filed to raise $55,251,088First money in 2025-12-03Raised so far $55,251,088HQ (as filed) Sydney NswSector Biotech ✓Stage (inferred) GrowthCall status Needs classification
Source linked the Form D on EDGAR↗Website verified kaziatherapeutics.com↗Named in the filing 7 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.